The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-{Methyl[4-(trifluoromethoxy)phenyl]amino}-N-[2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyridine-3-carboxamide ID: ALA4090644
PubChem CID: 137644051
Max Phase: Preclinical
Molecular Formula: C26H27BF3N3O4
Molecular Weight: 513.33
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN(c1ccc(OC(F)(F)F)cc1)c1ccc(C(=O)Nc2ccccc2B2OC(C)(C)C(C)(C)O2)cn1
Standard InChI: InChI=1S/C26H27BF3N3O4/c1-24(2)25(3,4)37-27(36-24)20-8-6-7-9-21(20)32-23(34)17-10-15-22(31-16-17)33(5)18-11-13-19(14-12-18)35-26(28,29)30/h6-16H,1-5H3,(H,32,34)
Standard InChI Key: WEOPPTJDPGFTCA-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 40 0 0 0 0 0 0 0 0999 V2000
9.2403 -15.2005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2591 -14.8168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8043 -13.5438 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
17.1278 -14.0010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5512 -17.7266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1222 -14.8269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1103 -15.2213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6623 -16.0330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2333 -13.5454 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
13.5365 -16.0496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0221 -17.3391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0179 -18.1641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0790 -16.5272 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.6701 -15.2096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3825 -16.4529 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.6889 -14.8229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5174 -14.7821 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.2368 -16.0240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8377 -18.1373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9570 -14.7898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6925 -13.9934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5183 -13.9571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8180 -16.4623 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.9478 -16.4402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2606 -13.9909 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.5140 -13.1309 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
16.4130 -13.5844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5422 -15.2238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9683 -15.2319 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.8288 -14.8086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7393 -16.5707 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.4016 -15.2360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8387 -17.3141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3056 -17.7480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1011 -16.0421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3944 -16.0603 0.0000 B 0 0 0 0 0 0 0 0 0 0 0 0
11.3791 -17.2701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8 24 2 0
32 6 2 0
23 35 1 0
19 33 1 0
22 26 1 0
15 8 1 0
17 22 1 0
22 3 1 0
33 5 1 0
13 33 1 0
32 36 1 0
20 1 1 0
28 30 2 0
16 21 2 0
1 18 2 0
27 21 1 0
35 7 2 0
13 36 1 0
34 11 1 0
2 25 2 0
7 30 1 0
11 12 1 0
4 27 2 0
31 11 1 0
10 23 2 0
36 31 1 0
6 4 1 0
29 16 1 0
1 17 1 0
8 14 1 0
2 29 1 0
14 20 2 0
35 15 1 0
2 28 1 0
18 24 1 0
16 32 1 0
28 10 1 0
22 9 1 0
11 33 1 0
15 37 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 513.33Molecular Weight (Monoisotopic): 513.2047AlogP: ┄#Rotatable Bonds: ┄Polar Surface Area: ┄Molecular Species: ┄HBA: ┄HBD: ┄#RO5 Violations: ┄HBA (Lipinski): ┄HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: ┄CX LogD: ┄Aromatic Rings: ┄Heavy Atoms: ┄QED Weighted: ┄Np Likeness Score: ┄
References 1. Ogiyama T, Yamaguchi M, Kurikawa N, Honzumi S, Yamamoto Y, Sugiyama D, Takakusa H, Inoue SI.. (2017) Identification of a novel hormone sensitive lipase inhibitor with a reduced potential of reactive metabolites formation., 25 (7): [PMID:28279560 ] [10.1016/j.bmc.2017.02.045 ]